Proteomics in HepG2 hepatocarcinoma cells with stably silenced expression of PRDX1

Journal of Proteomics

Volumn 79, Issue , 2013, Pages 161-171

  Aguilar Melero, Patricia ^a   Prieto Álamo, María José ^a   Jurado, Juan ^a   Holmgren, Arne ^b   Pueyo, Carmen ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Hepatocarcinoma; Peroxiredoxin 1; Protein expression profiles; Short hairpin RNA; Thiol protein oxidation

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; BETA CATENIN; CASPASE 3; GAMMA GLUTAMYLTRANSFERASE; MESSENGER RNA; OSTEOPONTIN; PEROXIREDOXIN 1; PROTEIN BAX; PROTEIN C FOS; SHORT HAIRPIN RNA; UVOMORULIN;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CARCINOMA; OXIDATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; UPREGULATION; WESTERN BLOTTING;

CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; DOWN-REGULATION; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; PEROXIREDOXINS; PROTEOMICS; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 84872418223     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.12.005     Document Type: Article

References (59)

1. Santamaria E., Munoz J., Fernandez-Irigoyen J., Prieto J., Corrales F.J. Toward the discovery of new biomarkers of hepatocellular carcinoma by proteomics. Liver Int 2007, 27:163-173.
2. Immenschuh S., Baumgart-Vogt E. Peroxiredoxins, oxidative stress, and cell proliferation. Antioxid Redox Signal 2005, 7:768-777.
3. Neumann C.A., Cao J., Manevich Y. Peroxiredoxin 1 and its role in cell signaling. Cell Cycle 2009, 8:4072-4078.
4. Neumann C.A., Krause D.S., Carman C.V., Das S., Dubey D.P., Abraham J.L., et al. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature 2003, 424:561-565.
5. Song I.S., Kim S.U., Oh N.S., Kim J., Yu D.Y., Huang S.M., et al. Peroxiredoxin I contributes to TRAIL resistance through suppression of redox-sensitive caspase activation in human hepatoma cells. Carcinogenesis 2009, 30:1106-1114.
6. Zhang B., Wang Y., Su Y. Peroxiredoxins, a novel target in cancer radiotherapy. Cancer Lett 2009, 286:154-160.
7. Gao M.C., Jia X.D., Wu Q.F., Cheng Y., Chen F.R., Zhang J. Silencing Prx1 and/or Prx5 sensitizes human esophageal cancer cells to ionizing radiation and increases apoptosis via intracellular ROS accumulation. Acta Pharmacol Sin 2011, 32:528-536.
8. Du Z.X., Yan Y., Zhang H.Y., Liu B.Q., Gao Y.Y., Niu X.F., et al. Suppression of MG132-mediated cell death by peroxiredoxin 1 through influence on ASK1 activation in human thyroid cancer cells. Endocr Relat Cancer 2010, 17:553-560.
9. Kim Y.J., Lee W.S., Ip C., Chae H.Z., Park E.M., Park Y.M. Prx1 suppresses radiation-induced c-Jun NH2-terminal kinase signaling in lung cancer cells through interaction with the glutathione S-transferase Pi/c-Jun NH2-terminal kinase complex. Cancer Res 2006, 66:7136-7142.
10. Chen M.F., Keng P.C., Shau H., Wu C.T., Hu Y.C., Liao S.K., et al. Inhibition of lung tumor growth and augmentation of radiosensitivity by decreasing peroxiredoxin I expression. Int J Radiat Oncol Biol Phys 2006, 64:581-591.
11. Chen M.F., Lee K.D., Yeh C.H., Chen W.C., Huang W.S., Chin C.C., et al. Role of peroxiredoxin I in rectal cancer and related to p53 status. Int J Radiat Oncol Biol Phys 2010, 78:868-878.
12. Moffat J., Grueneberg D.A., Yang X., Kim S.Y., Kloepfer A.M., Hinkle G., et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 2006, 124:1283-1298.
13. Jurado J., Fuentes-Almagro C.A., Prieto-Alamo M.J., Pueyo C. Alternative splicing of c-fos pre-mRNA: contribution of the rates of synthesis and degradation to the copy number of each transcript isoform and detection of a truncated c-Fos immunoreactive species. BMC Mol Biol 2007, 8:83.
14. Pueyo C., Jurado J., Prieto-Alamo M.J., Monje-Casas F., Lopez-Barea J. Multiplex reverse transcription-polymerase chain reaction for determining transcriptional regulation of thioredoxin and glutaredoxin pathways. Methods Enzymol 2002, 347:441-451.
15. Montes-Nieto R., Fuentes-Almagro C.A., Bonilla-Valverde D., Prieto-Alamo M.J., Jurado J., Carrascal M., et al. Proteomics in free-living Mus spretus to monitor terrestrial ecosystems. Proteomics 2007, 7:4376-4387.
16. Armstrong L., Hughes O., Yung S., Hyslop L., Stewart R., Wappler I., et al. The role of PI3K/AKT, MAPK/ERK and NFkappabeta signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis. Hum Mol Genet 2006, 15:1894-1913.
17. Mortz E., Krogh T.N., Vorum H., Gorg A. Improved silver staining protocols for high sensitivity protein identification using matrix-assisted laser desorption/ionization-time of flight analysis. Proteomics 2001, 1:1359-1363.
18. Baty J.W., Hampton M.B., Winterbourn C.C. Detection of oxidant sensitive thiol proteins by fluorescence labeling and two-dimensional electrophoresis. Proteomics 2002, 2:1261-1266.
19. Fuentes-Almagro C.A., Prieto-Álamo M.J., Pueyo C., Jurado J. Identification of proteins containing redox-sensitive thiols after PRDX1, PRDX3 and GCLC silencing and/or glucose oxidase treatment in Hepa 1-6 cells. J Proteomics 2012, 77:262-279.
20. Wong I.H., Lau W.Y., Leung T., Johnson P.J. Quantitative comparison of alpha-fetoprotein and albumin mRNA levels in hepatocellular carcinoma/adenoma, non-tumor liver and blood: implications in cancer detection and monitoring. Cancer Lett 2000, 156:141-149.
21. Pei Y., Kano J., Iijima T., Morishita Y., Inadome Y., Noguchi M. Overexpression of Dickkopf 3 in hepatoblastomas and hepatocellular carcinomas. Virchows Arch 2009, 454:639-646.
22. Woo H.A., Chae H.Z., Hwang S.C., Yang K.S., Kang S.W., Kim K., et al. Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation. Science 2003, 300:653-656.
23. Cao DX, Li ZJ, Jiang XO, Lum YL, Khin E, Lee NP, et al. Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers. World J Gastroenterol.18:3923-30.
24. Qin L.X., Tang Z.Y. The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol 2002, 8:385-392.
25. Zhou L., Liu J., Luo F. Serum tumor markers for detection of hepatocellular carcinoma. World J Gastroenterol 2006, 12:1175-1181.
26. Guo L., Song L., Wang Z., Zhao W., Mao W., Yin M. Panaxydol inhibits the proliferation and induces the differentiation of human hepatocarcinoma cell line HepG2. Chem Biol Interact 2009, 181:138-143.
27. Brandes N., Schmitt S., Jakob U. Thiol-based redox switches in eukaryotic proteins. Antioxid Redox Signal 2009, 11:997-1014.
28. Oktyabrsky O.N., Smirnova G.V. Redox regulation of cellular functions. Biochemistry (Mosc) 2007, 72:132-145.
29. Baty J.W., Hampton M.B., Winterbourn C.C. Proteomic detection of hydrogen peroxide-sensitive thiol proteins in Jurkat cells. Biochem J 2005, 389:785-795.
30. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411:494-498.
31. Neumann C.A., Fang Q. Are peroxiredoxins tumor suppressors?. Curr Opin Pharmacol 2007, 7:375-380.
32. Zhang B., Su Y., Ai G., Wang Y., Wang T., Wang F. Involvement of peroxiredoxin I in protecting cells from radiation-induced death. J Radiat Res 2005, 46:305-312.
33. Zhang B., Wang Y., Liu K., Yang X., Song M., Wang Y., et al. Adenovirus-mediated transfer of siRNA against peroxiredoxin I enhances the radiosensitivity of human intestinal cancer. Biochem Pharmacol 2008, 75:660-667.
34. Chang R., Wang E. Mouse translation elongation factor eEF1A-2 interacts with Prdx-I to protect cells against apoptotic death induced by oxidative stress. J Cell Biochem 2007, 100:267-278.
35. Kim S.Y., Kim T.J., Lee K.Y. A novel function of peroxiredoxin 1 (Prx-1) in apoptosis signal-regulating kinase 1 (ASK1)-mediated signaling pathway. FEBS Lett 2008, 582:1913-1918.
36. Liu Z., Ahn J.Y., Liu X., Ye K. Ebp1 isoforms distinctively regulate cell survival and differentiation. Proc Natl Acad Sci U S A 2006, 103:10917-10922.
37. Guo L., Fang H., Collins J., Fan X.H., Dial S., Wong A., et al. Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor alpha agonists. BMC Bioinformatics 2006, 7(Suppl. 2):S18.
38. Sorof S. Modulation of mitogenesis by liver fatty acid binding protein. Cancer Metastasis Rev 1994, 13:317-336.
39. Suzuki T., Watanabe K., Ono T. Immunohistochemical demonstration of liver fatty acid-binding protein in human hepatocellular malignancies. J Pathol 1990, 161:79-83.
40. Hamaguchi T., Iizuka N., Tsunedomi R., Hamamoto Y., Miyamoto T., Iida M., et al. Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma. Int J Oncol 2008, 33:725-731.
41. Shenton D., Grant C.M. Protein S-thiolation targets glycolysis and protein synthesis in response to oxidative stress in the yeast Saccharomyces cerevisiae. Biochem J 2003, 374:513-519.
42. Fratelli M., Demol H., Puype M., Casagrande S., Eberini I., Salmona M., et al. Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes. Proc Natl Acad Sci U S A 2002, 99:3505-3510.
43. Vander Heiden M.G., Cantley L.C., Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033.
44. Modaressi S., Brechtel K., Christ B., Jungermann K. Human mitochondrial phosphoenolpyruvate carboxykinase 2 gene. Structure, chromosomal localization and tissue-specific expression. Biochem J 1998, 333(Pt 2):359-366.
45. DeBerardinis R.J., Cheng T. Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene 2010, 29:313-324.
46. Kang H.J., Koh K.H., Yang E., You K.T., Kim H.J., Paik Y.K., et al. Differentially expressed proteins in gastrointestinal stromal tumors with KIT and PDGFRA mutations. Proteomics 2006, 6:1151-1157.
47. Wang J.W., Peng S.Y., Li J.T., Wang Y., Zhang Z.P., Cheng Y., et al. Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1. Cancer Lett 2009, 281:71-81.
48. Choi M.M., Kim E.A., Huh J.W., Choi S.Y., Cho S.W., Yang S.J. Small-interfering-RNA-mediated silencing of human glutamate dehydrogenase induces apoptosis in neuroblastoma cells. Biotechnol Appl Biochem 2008, 51:107-110.
49. Smith T.J., Stanley C.A. Untangling the glutamate dehydrogenase allosteric nightmare. Trends Biochem Sci 2008, 33:557-564.
50. Choi M.M., Huh J.W., Yang S.J., Cho E.H., Choi S.Y., Cho S.W. Identification of ADP-ribosylation site in human glutamate dehydrogenase isozymes. FEBS Lett 2005, 579:4125-4130.
51. Snell K., Weber G. Enzymic imbalance in serine metabolism in rat hepatomas. Biochem J 1986, 233:617-620.
52. Urrutia R. KRAB-containing zinc-finger repressor proteins. Genome Biol 2003, 4:231.
53. Wu C., Luo Z., Chen X., Wu C., Yao D., Zhao P., et al. Two-dimensional differential in-gel electrophoresis for identification of gastric cancer-specific protein markers. Oncol Rep 2009, 21:1429-1437.
54. Webster K.A., Prentice H., Bishopric N.H. Oxidation of zinc finger transcription factors: physiological consequences. Antioxid Redox Signal 2001, 3:535-548.
55. Ciechanover A. Intracellular protein degradation from a vague idea through the lysosome and the ubiquitin-proteasome system and on to human diseases and drug targeting: Nobel Lecture, December 8, 2004. Ann N Y Acad Sci 2007, 1116:1-28.
56. Knecht E., Aguado C., Carcel J., Esteban I., Esteve J.M., Ghislat G., et al. Intracellular protein degradation in mammalian cells: recent developments. Cell Mol Life Sci 2009, 66:2427-2443.
57. Keller J.N., Dimayuga E., Chen Q., Thorpe J., Gee J., Ding Q. Autophagy, proteasomes, lipofuscin, and oxidative stress in the aging brain. Int J Biochem Cell Biol 2004, 36:2376-2391.
58. Frezza M., Schmitt S., Dou Q.P. Targeting the ubiquitin-proteasome pathway: an emerging concept in cancer therapy. Curr Top Med Chem 2011, 11:2888-2905.
59. Repnik U., Stoka V., Turk V., Turk B. Lysosomes and lysosomal cathepsins in cell death. Biochim Biophys Acta 2012, 1824:22-33.